DET MS en es it fr

DET MS Brand names, DET MS Analogs

DET MS Brand Names Mixture

  • No information avaliable

DET MS Chemical_Formula

C33H37N5O5

DET MS RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

DET MS fda sheet

DET_MS FDA

DET MS msds (material safety sheet)

DET_MS MSDS

DET MS Synthesis Reference

No information avaliable

DET MS Molecular Weight

583.678 g/mol

DET MS Melting Point

No information avaliable

DET MS H2O Solubility

No information avaliable

DET MS State

Solid

DET MS LogP

No information avaliable

DET MS Dosage Forms

Liquid

DET MS Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

DET MS Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

DET MS Absorption

Interpatient variable and may be dependent on the administration technique

DET MS side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

DET MS Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

DET MS Organisms Affected

Humans and other mammals